Targeting the D1-N-methyl-d-aspartate receptor complex reduces l-dopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats

L-3,4-dihydroxyphenylalanine (l-dopa) remains the most effective therapy for Parkinson’s disease (PD), but its long-term administration is associated with the development of debilitating motor complications known as l-dopa-induced dyskinesia (LID). Enhanced function of dopamine D1 receptor (D1R) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Lu, Zhang, Zhanzhao, Hu, Rongguo, Cheng, Jie, Li, Lin, Fan, Qinyi, Wu, Na, Gan, Jing, Zhou, Mingzhu, Liu, Zhenguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745842/
https://www.ncbi.nlm.nih.gov/pubmed/26893543
http://dx.doi.org/10.2147/DDDT.S93487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745842/
https://www.ncbi.nlm.nih.gov/pubmed/26893543
http://dx.doi.org/10.2147/DDDT.S93487

Ejemplares similares